This topic contains a solution. Click here to go to the answer

Author Question: BRCA1 is a genetic mutation that increases the risk of cervical cancer. Indicate whether the ... (Read 36 times)

strangeaffliction

  • Hero Member
  • *****
  • Posts: 660
BRCA1 is a genetic mutation that increases the risk of cervical cancer.
 
  Indicate whether the statement is true or false

Question 2

Cryosurgery uses liquid nitrogen to ________ and destroy abnormal tissue.
 
  A) burn
  B) identify
  C) coagulate
  D) freeze



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Jordin Calloway

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

FALSE
Explanation: BRCA1 increases the risk of breast (BR) cancer (CA).

Answer to Question 2

D
Explanation: A) Cryosurgery does not burn and destroy abnormal tissue.
B) Cryosurgery is not used to identify abnormal tissue.
C) Cryosurgery does not coagulate and destroy abnormal tissue.
D) Correct Cry/o- means cold.




strangeaffliction

  • Member
  • Posts: 660
Reply 2 on: Jun 27, 2018
Excellent


yeungji

  • Member
  • Posts: 319
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

A recent study has found that following a diet rich in berries may slow down the aging process of the brain. This diet apparently helps to keep dopamine levels much higher than are seen in normal individuals who do not eat berries as a regular part of their diet as they enter their later years.

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library